Using immunohistochemistry staining, Tang and Dai et al [17] found that CTHRC1 expression is absent in the benign nevi or noninvasive stages of melanoma (melanoma in situ) and dramatically increases in the invasive and metastatic melanoma. The gene discussed is CTHRC1; the disease is in situ carcinoma.